In vitro-in vivo correlation of the effect of supersaturation on the intestinal absorption of BCS Class 2 drugs.
The aim of this study was to establish an in vitro method for evaluating the effect of supersaturation on oral absorption of poorly water-soluble drugs in vivo. Albendazole, dipyridamole, gefitinib, and ketoconazole were used as model drugs. Supersaturation of each drug was induced by diluting its stock solution by fasted state simulated intestinal fluid (FaSSIF) (solvent-shift method), then dissolution and precipitation profile of the drug was observed in vitro. The crystalline form of the precipitate was checked by differential scanning calorimetry (DSC). For comparison, control suspension was prepared by suspending a drug powder directly into FaSSIF (powder-suspending method). In vivo intestinal absorption of the drug was observed in rats by determined the plasma concentration after intraduodenal administration of drug suspensions. For all drugs, suspensions prepared by solvent-shift method showed significantly higher dissolved concentration in vitro than that prepared by powder-suspending method, clearly indicated the induction of supersaturation. DSC analysis revealed that crystalline form of the precipitate profoundly affects the extent and the duration of supersaturation. A rat in vivo study confirmed that the supersaturation of these drugs increased the fraction absorbed from the intestine, which corresponded well to the in vitro dissolution and precipitation profile of drugs except for ketoconazole. For ketoconazole, an in vivo absorption study was performed in rats pretreated with 1-aminobenzotriazole, a potent inhibitor of CYP mediated metabolism. CYP inhibition study suggested that the high luminal concentration of ketoconazole caused by supersaturation saturated the metabolic enzymes and further increased the systemic exposure of the absorbed drug. The additional effects of supersaturation on the absorption of ketoconazole are consistent with previous studies in humans under differing gastric pH conditions. In conclusion, effects of supersaturation on the intestinal absorption of poorly water-soluble drugs could be predicted from in vitro dissolution and a precipitation study. However if supersaturation affects the pharmacokinetic profiles of drugs, such as a first-pass metabolism, a combination with in vivo study should be required to evaluate its impact on oral bioavailability.
Faculty of Pharmaceutical Sciences, Setsunan University , 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan.
Haruki
H
Higashino
Tsubasa
T
Hasegawa
Mari
M
Yamamoto
Rie
R
Matsui
Yoshie
Y
Masaoka
Makoto
M
Kataoka
Shinji
S
Sakuma
Shinji
S
Yamashita
D000284:Administration, Oral; D015766:Albendazole / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology*; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology; D002152:Calorimetry, Differential Scanning; D065692:Cytochrome P-450 CYP3A Inhibitors / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology; D004176:Dipyridamole / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology*; D004355:Drug Stability; D000077156:Gefitinib; D066298:In Vitro Techniques; D007408:Intestinal Absorption / Q000187:drug effects*; D007654:Ketoconazole / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology*; D008297:Male; D011799:Quinazolines / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012995:Solubility; D012997:Solvents; D050257:Tubulin Modulators / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology
D000970:Antineoplastic Agents; D065692:Cytochrome P-450 CYP3A Inhibitors; D011799:Quinazolines; D012997:Solvents; D050257:Tubulin Modulators; D014665:Vasodilator Agents; D004176:Dipyridamole; D015766:Albendazole; D007654:Ketoconazole; D000077156:Gefitinib
in vitro−in vivo correlation; oral drug absorption; poorly water-soluble drugs; supersaturation